MACCALLINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 4.609
EU - Europa 3.599
AS - Asia 3.045
SA - Sud America 321
AF - Africa 44
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.624
Nazione #
US - Stati Uniti d'America 4.487
SG - Singapore 1.105
CN - Cina 949
IT - Italia 880
IE - Irlanda 485
TR - Turchia 439
UA - Ucraina 425
SE - Svezia 421
FR - Francia 303
GB - Regno Unito 298
BR - Brasile 281
IN - India 248
DE - Germania 218
VN - Vietnam 152
PL - Polonia 147
FI - Finlandia 119
CA - Canada 84
RU - Federazione Russa 76
AT - Austria 69
ES - Italia 43
CZ - Repubblica Ceca 25
MX - Messico 25
JP - Giappone 23
BE - Belgio 22
LT - Lituania 19
NL - Olanda 19
BD - Bangladesh 17
ZA - Sudafrica 17
HK - Hong Kong 15
KR - Corea 13
AR - Argentina 12
IQ - Iraq 9
ID - Indonesia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 7
MY - Malesia 6
TW - Taiwan 6
CL - Cile 5
EC - Ecuador 5
MA - Marocco 5
PT - Portogallo 5
SA - Arabia Saudita 5
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
PH - Filippine 4
UZ - Uzbekistan 4
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 11.624
Città #
Singapore 825
Chandler 605
Jacksonville 511
Dublin 477
Ashburn 344
Izmir 282
Beijing 237
Dearborn 233
Dallas 220
Chieti 211
Southend 198
Princeton 194
Nanjing 150
The Dalles 136
Los Angeles 122
Ann Arbor 119
Santa Clara 113
Kraków 108
Cambridge 103
Wilmington 96
New York 72
Nanchang 66
Altamura 62
Pescara 62
Vienna 56
Tongling 55
Munich 53
Buffalo 51
Ho Chi Minh City 51
Boardman 47
Bosa 40
São Paulo 37
Houston 35
Warsaw 35
Shenyang 34
Teramo 33
Woodbridge 32
Hebei 31
Helsinki 31
Jiaxing 30
Brooklyn 29
Kocaeli 28
Redondo Beach 28
Tianjin 28
Denver 26
Kunming 26
Hanoi 25
Jinan 25
Atlanta 23
Brno 23
Hefei 23
Rome 23
Brussels 22
Chennai 21
Ottawa 21
Toronto 21
Washington 21
Changsha 20
Tokyo 20
Fairfield 19
Montreal 18
Ningbo 18
Orem 18
Hangzhou 17
Stockholm 17
London 16
Milan 15
Turku 15
Nuremberg 14
Poplar 13
Bologna 12
Falls Church 12
Guangzhou 12
Hong Kong 12
Johannesburg 12
Norwalk 12
Phoenix 12
Rio de Janeiro 12
Ankara 11
Dong Ket 11
Amsterdam 10
Chicago 10
Como 10
San Francisco 10
Seattle 10
Augusta 9
Biên Hòa 9
Mexico City 9
Orange 9
Zhengzhou 9
Auburn Hills 8
Changchun 8
Moscow 8
Pune 8
Redwood City 8
Seoul 8
Bari 7
Haiphong 7
Manchester 7
Mumbai 7
Totale 7.119
Nome #
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 231
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 175
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 170
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 168
Anticancer Activity of Stilbene-Based Derivatives 158
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 154
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 151
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 151
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 150
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 149
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 148
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 146
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 140
Recent developments of amidine-like compounds as selective NOS inhibitors 139
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 139
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 139
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 138
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 138
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 136
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 136
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 135
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools 133
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 132
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 132
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 132
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 130
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 129
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 129
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 128
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 128
null 128
Convergent Solution Phase and Solid Phase Synthesis for the Preparation of beta- Lactam antibiotic libraries. 125
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 125
Synthetic Strategies to Serine-Proline Chimeras: An Overview 125
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 124
Synthesis and antiplatelet activity of clofibric acid analogues 123
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 123
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 122
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 122
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 122
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 121
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 119
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 117
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 115
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 114
Amidine-Based Compounds Affecting L-Arginine Metabolism 113
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 113
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 113
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 112
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 112
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 112
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 112
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 111
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 110
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 109
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 109
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 107
Structural development studies of PPARs ligands based on tyrosine scaffold 107
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 106
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 106
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on the Mitsunobu reaction 105
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 104
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 104
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 103
Synthetic methodologies for the preparation of arginine-proline derivatives 102
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 100
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 100
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 100
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 98
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 97
N-substituted acetamidines as nitric oxide synthase inhibitors 96
“Insight into diastereospecific solvolysis of peptidyl-b-lactams: combined kinetic and conformational studies” 96
Targeting iNOS As a Valuable Strategy for the Therapy of Glioma 95
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 94
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 93
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 93
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 92
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 92
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 91
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 91
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 91
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 89
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 88
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 88
Methods to Evaluate the Activity of Nitric Oxide Synthase 87
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 87
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 86
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial Cells 86
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 86
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 82
Insights into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 81
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 81
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 81
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 80
Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis 80
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 78
N-Acylsulfonylamides as a new class of PPARa antagonists 77
Preformulation studies and estimation of brain penetration for two alpidem analogues having anticonvulsant activity 74
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 72
Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents 71
Totale 11.432
Categoria #
all - tutte 46.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021493 0 0 0 0 0 134 16 52 122 105 14 50
2021/2022661 13 13 22 105 70 18 24 49 97 30 71 149
2022/20231.712 124 243 127 169 162 345 88 129 213 21 56 35
2023/2024791 56 26 73 21 48 250 192 10 3 30 8 74
2024/20252.063 92 394 348 46 37 95 116 124 176 94 269 272
2025/20262.243 354 150 411 600 538 190 0 0 0 0 0 0
Totale 12.237